Morris Muliaditan

Stevenage, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery of antibodies.

Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery of antibodies.

Journal: mAbs

Published: June 26, 2025

Development of a Joint Tumor Size-Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision-Making.

Development of a Joint Tumor Size-Overall Survival Modeling and Simulation Framework Supporting Oncology Development Decision-Making.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 18, 2024

Tutorial on Conditional Simulations With a Tumor Size-Overall Survival Model to Support Oncology Drug Development.

Tutorial on Conditional Simulations With a Tumor Size-Overall Survival Model to Support Oncology Drug Development.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 18, 2024

Application of quantitative protein mass spectrometric data in the early predictive analysis of membrane-bound target engagement by monoclonal antibodies.

Application of quantitative protein mass spectrometric data in the early predictive analysis of membrane-bound target engagement by monoclonal antibodies.

Journal: mAbs

Published: May 03, 2024

Application of quantitative protein mass spectrometric data in the early predictive analysis of target engagement by monoclonal antibodies.

Application of quantitative protein mass spectrometric data in the early predictive analysis of target engagement by monoclonal antibodies.

Journal: Clinical and translational science

Published: December 10, 2021

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.

Journal: Nature cancer

Published: November 18, 2021

Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: Implications for dose selection.

Prediction of lung exposure to anti-tubercular drugs using plasma pharmacokinetic data: Implications for dose selection.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 27, 2021

Bacterial growth dynamics and pharmacokinetic-pharmacodynamic relationships of rifampicin and bedaquiline in BALB/c mice.

Bacterial growth dynamics and pharmacokinetic-pharmacodynamic relationships of rifampicin and bedaquiline in BALB/c mice.

Journal: British journal of pharmacology

Published: November 08, 2020

Optimizing β-Lactams against Tuberculosis.

Optimizing β-Lactams against Tuberculosis.

Journal: American journal of respiratory and critical care medicine

Published: January 11, 2020

Evaluation of pharmacokinetic-pharmacodynamic relationships and selection of drug combinations for tuberculosis.

Evaluation of pharmacokinetic-pharmacodynamic relationships and selection of drug combinations for tuberculosis.

Journal: British journal of clinical pharmacology

Published: June 28, 2019

How long will treatment guidelines for TB continue to overlook variability in drug exposure?

How long will treatment guidelines for TB continue to overlook variability in drug exposure?

Journal: The Journal of antimicrobial chemotherapy

Published: June 10, 2019

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.

First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.

Journal: Antimicrobial agents and chemotherapy

Published: February 01, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026